G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1 Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.27. G1 Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Marathon Digital Holdings, Inc. (NASDAQ:MARA) Q4 2023 Earnings Call Transcript February 28, 2024 Marathon Digital Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, welcome to Marathon Digital Holdings Fourth Quarter and Fiscal Year […]
The TJX Companies, Inc. (NYSE:TJX) Q4 2024 Earnings Call Transcript February 28, 2024 The TJX Companies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to The TJX Companies Fourth Quarter […]